Concepedia
Statistics
Publications
39
Citations
3.1K
H-Index
27
Active since
1996
Affiliations
Universität Innsbruck(Current)
Innsbruck Medical University
German Cancer Research Center
Oroboros Instruments (Austria)
University of Florence
Iris E. Eder is an author at Universität Innsbruck specializing in oncology, prostate cancer, and medicine.
Publications per year
1996–2024
Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor.
Alfred Hobisch, Iris E. Eder, Thomas Pütz et al. · PubMed · 1998 · 439 citations
Life Sciences, Endocrinology, Oncology +13
Switch from antagonist to agonist of the androgen receptor blocker bicalutamide is associated with prostate tumour progression in a new model system
Zoran Čulig, Jens Hoffmann, Martin Erdel et al. · British Journal of Cancer · 1999 · 421 citations · Full text
Medicine, Oncology, Pharmacology +17
The Glucocorticoid Receptor Is a Key Player for Prostate Cancer Cell Survival and a Target for Improved Antiandrogen Therapy
Martin Puhr, Julia Hoefer, Andrea Eigentler et al. · Clinical Cancer Research · 2017 · 170 citations · Full text
Medicine, Oncology, Pharmacology +16
Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines.
Thomas Pütz, Zoran Čulig, Iris E. Eder et al. · PubMed · 1999 · 159 citations
Life Sciences, Biochemistry, Oncology +17
Inhibition of LNCaP prostate cancer cells by means of androgen receptor antisense oligonucleotides
Iris E. Eder, Zoran Čulig, Reinhold Ramoner et al. · Cancer Gene Therapy · 2000 · 156 citations
Life Sciences, Molecular Biology, Oncology +13
1–5 of 39